80 related articles for article (PubMed ID: 26438628)
1. In Vitro and In Vivo Mechanistic Studies toward Understanding the Role of 1-Aminobenzotriazole in Rat Drug-Drug Interactions.
Boily MO; Chauret N; Laterreur J; Leblond FA; Boudreau C; Duquet MC; Lévesque JF; Ste-Marie L; Pichette V
Drug Metab Dispos; 2015 Dec; 43(12):1960-5. PubMed ID: 26438628
[TBL] [Abstract][Full Text] [Related]
2. 1-Aminobenzotriazole modulates oral drug pharmacokinetics through cytochrome P450 inhibition and delay of gastric emptying in rats.
Stringer RA; Weber E; Tigani B; Lavan P; Medhurst S; Sohal B
Drug Metab Dispos; 2014 Jul; 42(7):1117-24. PubMed ID: 24727486
[TBL] [Abstract][Full Text] [Related]
3. Effect of pretreatment regimens of 1-aminobenzotriazole on metabolism and gastric emptying of probe compounds in rat.
Padmanabhan S; Kaur H; Rao A; Saxena A; Gupta YK; Mariappan TT; Holenarsipur VK
Xenobiotica; 2019 Jun; 49(6):646-654. PubMed ID: 29898636
[TBL] [Abstract][Full Text] [Related]
4. In vivo use of the P450 inactivator 1-aminobenzotriazole in the rat: varied dosing route to elucidate gut and liver contributions to first-pass and systemic clearance.
Strelevitz TJ; Foti RS; Fisher MB
J Pharm Sci; 2006 Jun; 95(6):1334-41. PubMed ID: 16625658
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo characterization of CYP inhibition by 1-aminobenzotriazole in rats.
Parrish KE; Mao J; Chen J; Jaochico A; Ly J; Ho Q; Mukadam S; Wright M
Biopharm Drug Dispos; 2016 May; 37(4):200-11. PubMed ID: 26637499
[TBL] [Abstract][Full Text] [Related]
6. 1-Aminobenzotriazole, a known cytochrome P450 inhibitor, is a substrate and inhibitor of N-acetyltransferase.
Sun Q; Harper TW; Dierks EA; Zhang L; Chang S; Rodrigues AD; Marathe P
Drug Metab Dispos; 2011 Sep; 39(9):1674-9. PubMed ID: 21677062
[TBL] [Abstract][Full Text] [Related]
7. The use of the suicide CYP450 inhibitor ABT for distinguishing absorption and metabolism processes in in-vivo pharmacokinetic screens.
Caldwell GW; Ritchie DM; Masucci JA; Hageman W; Cotto C; Hall J; Hasting B; Jones W
Eur J Drug Metab Pharmacokinet; 2005; 30(1-2):75-83. PubMed ID: 16010865
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of drug metabolism in rat liver slices: IV. Comparison of ethoxycoumarin clearance by liver slices, isolated hepatocytes, and hepatic microsomes from rats pretreated with known modifiers of cytochrome P-450 activity.
Carlile DJ; Hakooz N; Houston JB
Drug Metab Dispos; 1999 Apr; 27(4):526-32. PubMed ID: 10101148
[TBL] [Abstract][Full Text] [Related]
9. 1-Aminobenzotriazole-induced destruction of hepatic and renal cytochromes P450 in male Sprague-Dawley rats.
Mugford CA; Mortillo M; Mico BA; Tarloff JB
Fundam Appl Toxicol; 1992 Jul; 19(1):43-9. PubMed ID: 1397800
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the Disposition of a Mixed Aldehyde Oxidase/Cytochrome P450 Substrate in Rats with Attenuated P450 Activity.
Crouch RD; Morrison RD; Byers FW; Lindsley CW; Emmitte KA; Daniels JS
Drug Metab Dispos; 2016 Aug; 44(8):1296-303. PubMed ID: 26936972
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of the cytochrome P450 mechanism-based inhibitor N-benzyl-1-aminobenzotriazole to products that covalently bind with protein in guinea pig liver and lung microsomes: comparative study with 1-aminobenzotriazole.
Woodcroft KJ; Webb CD; Yao M; Weedon AC; Bend JR
Chem Res Toxicol; 1997 May; 10(5):589-99. PubMed ID: 9168258
[TBL] [Abstract][Full Text] [Related]
12. Utility of food pellets containing 1-aminobenzotriazole for longer term in vivo inhibition of cytochrome P450 in mice.
Stringer R; Cordier V; Afatsawo C; Arabin P; Desrayaud S; Hoffmann L; Lehmann D; Lowe PJ; Risser F; Thiel J; Widmer T; Wipfli P; Bigaud M
Xenobiotica; 2019 Jan; 49(1):13-21. PubMed ID: 29299977
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of testicular steroid metabolism by administration of 1-aminobenzotriazole to rats.
Soltis M; Colby HD
Pharmacology; 1998 Jan; 56(1):51-6. PubMed ID: 9467188
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo evaluation of the effect of puerarin on hepatic cytochrome p450-mediated drug metabolism.
Kim SB; Yoon IS; Kim KS; Cho SJ; Kim YS; Cho HJ; Chung SJ; Chong S; Kim DD
Planta Med; 2014 May; 80(7):561-7. PubMed ID: 24710899
[TBL] [Abstract][Full Text] [Related]
15. 1-Aminobenzotriazole coincubated with (S)-warfarin results in potent inactivation of CYP2C9.
Sodhi JK; Ford KA; Mukadam S; Wong S; Hop CE; Khojasteh SC; Halladay JS
Drug Metab Dispos; 2014 May; 42(5):813-7. PubMed ID: 24550229
[TBL] [Abstract][Full Text] [Related]
16. Inactivation of adrenal cytochromes P450 by 1-aminobenzotriazole. Divergence of in vivo and in vitro actions.
Colby HD; Abbott B; Cachovic M; Debolt KM; Mico BA
Biochem Pharmacol; 1995 Apr; 49(8):1057-62. PubMed ID: 7748185
[TBL] [Abstract][Full Text] [Related]
17. Effective dosing regimen of 1-aminobenzotriazole for inhibition of antipyrine clearance in rats, dogs, and monkeys.
Balani SK; Zhu T; Yang TJ; Liu Z; He B; Lee FW
Drug Metab Dispos; 2002 Oct; 30(10):1059-62. PubMed ID: 12228180
[TBL] [Abstract][Full Text] [Related]
18. An in vitro digestion test that reflects rat intestinal conditions to probe the importance of formulation digestion vs first pass metabolism in Danazol bioavailability from lipid based formulations.
Anby MU; Nguyen TH; Yeap YY; Feeney OM; Williams HD; Benameur H; Pouton CW; Porter CJ
Mol Pharm; 2014 Nov; 11(11):4069-83. PubMed ID: 25265395
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic interaction between metoprolol and SP-8203 in rats: competitive inhibition for the metabolism of metoprolol by SP-8203 via hepatic CYP2D subfamily.
Han SY; Yoon I; Chin YW; Cho IW; Lee MG; Choi YH
Xenobiotica; 2012 Oct; 42(10):1017-27. PubMed ID: 22568632
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of oxygen-induced lung injury in rats by the mechanism-based cytochrome P-450 inhibitor, 1-aminobenzotriazole.
Moorthy B; Parker KM; Smith CV; Bend JR; Welty SE
J Pharmacol Exp Ther; 2000 Feb; 292(2):553-60. PubMed ID: 10640292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
